Insulin degludec achieves no added benefit over conventional treatmentInsulin degludec (trade name Tresiba) has been approved for adolescents and children...
Suspected cancer: authorities withdraw diabetes drug approval10/06/2011 After the diabetes drug Actos was already withdrawn in France yesterday, today, the...